18 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
lowered CV events in T2DM ... lowered CV events in T2DM ... events in CKD + T2DM ... with or without T2DM ... visualabstract #table
Adverse Effects of Antipsychotic Medications - Comparison Table

First Generation: chlopromazine, haloperidol, fluphenazine 
Second Generation: aripirazole, asenapine,
Medications - Comparison Table ... Side Effects: EPS/TD ... Dyslipidemia, Weight Gain/T2DM ... Profiles #Comparison #Table
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
#Diabetes #T2D ... #DM2 #Table #PrimaryCare
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... Management of Fever ... and clinically stable ... #neutropenic #fever ... #IDSA #Algorithm
PEMSource: Algorithm for fever WITHOUT source by Age
#Diagnosis #Management #Peds #Fever #Without #Source #Table #Algorithm #PEMSource
PEMSource: Algorithm ... for fever WITHOUT ... Management #Peds #Fever ... Without #Source #Table ... #Algorithm #PEMSource
IDSA Algorithm for the Management of Neutropenic Fever - Reassess after 2-4 days of empirical antibiotic
IDSA Algorithm for ... of Neutropenic Fever ... #neutropenic #fever ... #IDSA #Algorithm
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... Neutropenic Fever ... and Prolonged Fever ... and clinically stable ... #IDSA #Algorithm
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Ozempic), or daily tablet ... patients with T2D
Abnormal liver function tests algorithm.
 This figure details the initial response to abnormal liver blood tests.
function tests algorithm ... liver disease; T2DM ... LFTs #Abnormal #Algorithm
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD ... insulin by ~20% • Never ... pharmacology #comparison #table